AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, ...

Full Waveform Inversion (FWI) is capable of finely characterizing the velocity structure, anisotropy, viscoelasticity, and attenuation properties of subsurface media, which provides critical ...

And, as usual, music helped a good deal: while drafting, I was listening to a lot of TAMTAM, bjons, Lady Wray, and wave to ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...

As of January 31st, 2025, we held $12.9 million in cash compared to $3.5 million at the fiscal year-end 2024. This increase was driven by the successful execution of our ATM program, through which we ...

(" Kelun-Biotech " or the " Company ", Stock Code: 6990.HK) announced its audited consolidated results for the year ended December 31, 2024 (the " Reporting Period "). In 2024, the pharmaceutical and ...

This isn’t a maybe – it’s an inevitability. Early investors will be the ones positioned to ride the wave of this technological tsunami. Ground Floor Opportunity: Remember the early days of ...

The world’s first approved antibody-drug conjugate, where a targeted antibody ... looks set to change rapidly in the coming years, thanks to a wave of innovation including CAR-T and other ...